Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Sarcoma 1Gynecologic 1

Conditions

Small Cell Lung Carcinoma 2Thymoma 1Testicular Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 2Taxes 2Peripheral Blood Stem Cell Transplantation 2Etoposide 2Carboplatin 2veliparib 1trastuzumab deruxtecan 1tipifarnib 1sargramostim 1isophosphamide mustard 1fludarabine phosphate 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1entinostat 1cc-486 1brodalumab 1aldesleukin 1Radiotherapy 1Radiosurgery 1Quality of Life 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Paclitaxel 1Nicotine 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Levofloxacin 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × isophosphamide mustard × Thoracic × Clear all
NCT01242072 2012-07-18

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Alaunos Therapeutics

Phase 1 Unknown
12 enrolled
GenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Osteosarcoma, Testicular Neoplasms, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡